Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 11:27 PM
Study NCT ID:
NCT06180993
Status:
RECRUITING
Last Update Posted:
2023-12-26
First Post:
2023-12-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Evaluation of the Effectiveness and Impact of Nirsevimab Administered as Routine Immunization
Sponsor:
Federico Martinón Torres
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-25
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-08
First Submit QC Date:
None
Study First Post Date:
2023-12-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-21
Last Update Post Date:
2023-12-26
Last Update Post Date Type:
ACTUAL